The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
- Conditions
- IPMN, PancreaticPancreas CancerPancreatic Cyst
- Interventions
- Diagnostic Test: LINFU®Diagnostic Test: Standard imaging tests
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Adenocyte, LLC
- Target Recruit Count
- 500
- Registration Number
- NCT06276764
- Locations
- 🇺🇸
Manhattan Endoscopy Center, New York, New York, United States
The LINFU® U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease
Not yet recruiting
- Conditions
- JaundiceAbdominal NeoplasmPancreatic Cancer
- Interventions
- Diagnostic Test: LINFU® (Low Intensity Non-Focused Ultrasound excitation of the pancreas)
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Adenocyte, LLC
- Target Recruit Count
- 1000
- Registration Number
- NCT06276738
The LINFU® U.S. Registry for the in the General Population Without Risk Factors
Not yet recruiting
- Conditions
- Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Dysplasia
- Interventions
- Diagnostic Test: LINFU®
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Adenocyte, LLC
- Target Recruit Count
- 500
- Registration Number
- NCT06276803
The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma
- Conditions
- Pancreatic Intraepithelial NeoplasiaPancreatic Adenocarcinoma
- First Posted Date
- 2023-12-06
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Adenocyte, LLC
- Target Recruit Count
- 1000
- Registration Number
- NCT06157671
- Locations
- 🇺🇸
Manhattan Endoscopy Center, New York, New York, United States
A Proof-of-Concept Study Evaluating LINFU™
Not Applicable
Completed
- Conditions
- Pancreas AdenocarcinomaDysplasia
- Interventions
- Diagnostic Test: LINFU™
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Adenocyte, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT05161013
- Locations
- 🇺🇸
Gastroenterology Associates of Sarasota, Sarasota, Florida, United States
Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- Combination Product: LINFU™ Technique
- First Posted Date
- 2021-03-11
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Adenocyte, LLC
- Target Recruit Count
- 500
- Registration Number
- NCT04793633
- Locations
- 🇺🇸
Sarasota Memorial HealthCare System, Sarasota, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath